General Surgery·Los Angeles, CA

Cedars-Sinai Medical Center

Signal lift21%58%+37 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
243–271
p10 – p90
Sample N
1,362
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.4%
6 of 104 applicants
01Cohort funnelthis cycle
N = 1,362
Applied
1,362
100.0%
Invited
104
7.6%
Class size
6
0.4%
J-1 visaCategoricalResearch
Your fitCedars-Sinai Medical Center Program

Create a free profile to see your personalized fit

Get started
Contact
FA
Program Director
Farin Amersi, MD
Email director
VC
Program Coordinator
Van Chau, BA
Email coordinator
Training sites2 hospitals · Los Angeles
  • 1
    Cedars-Sinai Medical Center
    Los Angeles, CA
    Primary
  • 2
    Children's Hospital Los Angeles
    Los Angeles, CA
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK243271
180205230255280

Level 2 CE data not available

Interview rates
US MD
13%
US DO
0%
US IMG
0%
Non-US IMG
1%
Applicant origin
In-state
19%
Out-of-state
7%
Interview prepGeneral Surgery
specialtyWhat drew you to surgery over medical specialties?★ common
specialtyAre you considering a fellowship after residency?★ common
clinicalDescribe your most challenging case in the OR.★ common
behavioralHow do you handle complications and bad outcomes?
clinicalWhat's your case log like?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesGeneral Surgery · 25-26
Save this program

Add Cedars-Sinai Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for General Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.